Human Amyloidbeta (1-40) (FL) Assay Kit

Catalog number: 27718-96Well
Brand: IBL Japan
Packing: 96well
Other sizes: Other sizes available
Price: On Request
Expected delivery time: 10 days

Product specifications for - Human Amyloidbeta (1-40) (FL) Assay Kit

Product group: Assays
Category: ELISA / EIA
Species: Human
Conjugation: HRP
Assay Sample Type: EDTA-plasma, Serum, CSF, Brain tissue extract, Cell culture supernatant
Assay Detection Range: 1.56 ~ 100 pg/mL
Datasheet: Datasheet
  Research Use Only
UNSPSC: 41116158
Form supplied: 1kit
Scientific information: 
Scientific info: The first case of Alzheimer's disease (AD) was defined and reported in 1907 by the German scientist, Dr. A. Alzheimer. His studies have shown that this is the main cause of dementia in the elderly. The plaques which appear in the brains of individuals who suffers AD patients are mostly constituted by the Amyloidbeta (Amyloid Beta) protein. Amyloid Beta is a peptide which consists of 40 or 42 (43) amino acids, and reports show that this is cleaved from beta- and gamma- secretase from the amyloid precursor protein. APP is a trans-membrane protein consisting of 695, 751, or 770 amino acids. Reports have shown many variants of Amyloid Beta exist and are clarified into the culture supernatant from the APP cDNA transfected mouse neuroblastoma cell. Furthermore, in 1995, a dominant and differential deposition of distinct betaamyloid peptide species, Amyloid Beta (N3pE), in senile plaques was found by Saido et al. This modified molecule, starting at the 3rd amino terminal residue, glutamate, was discovered to convert to pyroglutamate through intramolecular dehydration. This kit uses a monoclonal antibody as labeled antibody which was developed to react with N-terminal of Amyloid Beta specifically and not to react with APP. So this kit can measure only full-length Amyloid Beta of which N-terminal side is not cleaved ( FL means full-length). And further, the sensitivity and specificity of this kit is improved, compared to IBL Code No. 27714 Human Amyloid Beta (1-40) (N) Assay Kit. IBL has many other kinds of Amyloid Beta related products for AD research. They are very specific assay systems for each target and they can be used according to the purpose of study. The control set is available for sale on request.
Additional information: 
Synonyms: 27718; IBL Japan; Amyloid Beta Aβ 1-40 Full Length Human ELISA; Alzheimer's Disease / Amyloid beta Amyloid-beta/ Amyloid Beta / Abeta / Beta Amyloid
Mori T, Koyama N, Tan J, Segawa T, Maeda M, Town T. Combined treatment with the phenolics (-)-epigallocatechin-3-gallate and ferulic acid improves cognition and reduces Alzheimer-like pathology in mice. J Biol Chem. 2019;294(8):2714-2731. Read more
Izuo N, Kasahara C, Murakami K, et al. A Toxic Conformer of Aβ42 with a Turn at 22-23 is a Novel Therapeutic Target for Alzheimer's Disease. Sci Rep. 2017;7(1):11811. Read more
Mori T, Koyama N, Tan J, Segawa T, Maeda M, Town T. Combination therapy with octyl gallate and ferulic acid improves cognition and neurodegeneration in a transgenic mouse model of Alzheimer's disease. J Biol Chem. 2017;292(27):11310-11325. Read more
Jingami N, Asada-utsugi M, Uemura K, et al. Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer's disease. J Alzheimers Dis. 2015;45(1):109-15. Read more
Mori T, Koyama N, Segawa T, et al. Methylene blue modulates β-secretase, reverses cerebral amyloidosis, and improves cognition in transgenic mice. J Biol Chem. 2014;289(44):30303-17. Read more
Hook G, Yu J, Toneff T, Kindy M, Hook V. Brain pyroglutamate amyloid-β is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer's disease therapeutic. J Alzheimers Dis. 2014;41(1):129-49. Read more
Lemmin T, Dimitrov M, Fraering PC, Dal peraro M. Perturbations of the straight transmembrane α-helical structure of the amyloid precursor protein affect its processing by γ-secretase. J Biol Chem. 2014;289(10):6763-74. Read more
Bihaqi SW, Singh AP, Tiwari M. Supplementation of Convolvulus pluricaulis attenuates scopolamine-induced increased tau and amyloid precursor protein (AβPP) expression in rat brain. Indian J Pharmacol. 2012;44(5):593-8. Read more
Kakuda N, Shoji M, Arai H, et al. Altered γ-secretase activity in mild cognitive impairment and Alzheimer's disease. EMBO Mol Med. 2012;4(4):344-52. Read more
Ray B, Reyes PF, Lahiri DK. Biochemical studies in Normal Pressure Hydrocephalus (NPH) patients: change in CSF levels of amyloid precursor protein (APP), amyloid-beta (Aβ) peptide and phospho-tau. J Psychiatr Res. 2011;45(4):539-47. Read more